IACP Pushes FDA Funding Restriction To Ensure Office-Use Compounding

IACP Pushes FDA Funding Restriction To Ensure Office-Use Compounding

The International Academy of Compounding Pharmacists is floating legislative language that would prevent FDA from using appropriated funds to restrict office use compounding in states where it is already allowed, the lobby group said, outlining the issue as one of three priorities during visits to Capitol Hill this week